Article Details
Retrieved on: 2021-04-22 11:48:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Delonix is focused on developing synthetic biology vaccine platforms. Huang Hanyang, an analyst at Industrial Securities, said China is driving drug ...
Article found on: www.shine.cn
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here